Table 2.

Change in absolute and modifiable Framingham 10-year risk of CHD

	Usual care (N = 461)	Intervention (N = 524)
Absolute Framingham risk
Baseline, mean (SE)	16.9 (0.26)	17.2 (0.25)
Month 6, mean (SE)	13.7 (0.27)	12.5 (0.25)
Adjusted† change in risk from baseline to month 6, LS mean (95% CI)**	−4.9§ (−5.5 to −4.3)	−6.3§ (−6.9 to −5.7)
Modifiable Framingham risk (% above ‘normal’)‡
Baseline, mean (SE)	221 (15.7)	192 (12.4)
Month 6, mean (SE)	117 (9.3)	87 (7.8)
Adjusted† change in risk from baseline to month 6, LS mean (95% CI)*	−96§ (−115 to −78)	−115§ (−133 to −97)

^*p < 0.05.

^**p < 0.001, for intervention vs. usual care.

^§p < 0.001 vs. baseline.

^†Data were adjusted for baseline risk and other covariates.

^‡Defined as the risk for a non-smoker of the same age, gender, not receiving antihypertensive treatment and with total cholesterol = 4.9 mmol/l (189 mg/dl), high-density lipoprotein cholesterol = 1.0 mmol/l (40 mg/dl) for males or 1.2 mmol/l (46 mg/dl) for females = 1.3 mmol/l (50 mg/dl), and systolic blood pressure = 139 mmHg (38). SE, standard error; LS, least square; CI, confidence interval.